Image

Myeloma in remission

About
Risks
Symptoms
Diagnosis
Prevention

Myeloma in remission refers to a state where the signs and symptoms of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow, have diminished or disappeared following treatment. Achieving remission can significantly improve a patient's quality of life and may vary in duration and depth, categorized as complete or partial remission. Ongoing monitoring is essential as there is a risk of relapse, even after initial successful treatment.

Despite being in remission, patients with myeloma remain at higher risk for complications related to their previous disease and treatment, including infections, bone damage, and kidney issues. Additionally, the risk of disease relapse persists, with some patients experiencing progression of the disease weeks, months, or even years after achieving remission. Therefore, regular follow-up care and monitoring of blood markers are crucial for early detection of any changes.

While in remission, many patients may not show any active symptoms of myeloma; however, some may still experience residual effects such as fatigue, bone pain, or anemia. It is also important for patients to remain vigilant for new symptoms that might indicate a relapse, such as increased weakness, unusual infections, or changes in kidney function. Awareness and communication with healthcare providers about any changes are vital in the management of their condition.

Myeloma, or multiple myeloma, is a type of blood cancer that arises from malignant plasma cells in the bone marrow. The exact causes of myeloma are not fully understood, but several risk factors have been identified, including age, family history, exposure to certain chemicals, and pre-existing medical conditions such as monoclonal gammopathy of undetermined significance (MGUS). Genetic mutations and environmental exposures may also play a role in the development of this cancer.

Diagnosis of myeloma in remission typically involves regular blood tests to monitor for the presence of monoclonal proteins and other markers indicative of myeloma activity. Imaging studies, such as X-rays or MRIs, may also be employed to assess bone health and detect any new lesions or fractures. Close collaboration with a hematologist ensures that any signs of relapse can be addressed promptly and effectively.

Treatment for myeloma in remission typically focuses on maintaining the remission state and monitoring for any signs of recurrence. This may include regular follow-ups with healthcare providers, blood tests to monitor urine and serum proteins, and imaging studies. While some patients may not require active treatment during remission, others may receive maintenance therapy with medications such as lenalidomide to prolong the period of remission and prevent relapse.

Preventing a relapse of myeloma in remission is challenging but can involve lifestyle modifications and adherence to medical follow-up. Patients are encouraged to maintain a healthy lifestyle, including a balanced diet, regular exercise, and managing stress, which may help support overall health. Additionally, ongoing clinical evaluations, including blood tests and imaging, are key to catching any signs of disease activity early, thus allowing for timely intervention.
On this page